A health worker vaccinates a farmer in a center in Alcarrás (Lleida), on May 22, 2021. (Photo: PAU BARRENA / AFP via Getty Images)
Read Also
- Alan Wake Remastered announcement to be made very soon Sep 5, 2021
- Francesco Oppini: did you have a fight with Tommaso Zorzi? New denial Jul 20, 2021
- Paolo Fox horoscope today Saturday 4 September 2021: Libra – Pisces Sep 4, 2021
- IRS Announces Sending 2.8 Million Refunds Under Biden’s $ 10,200 Unemployment Tax Waiver Jun 5, 2021
- Murders of Lola and Vanesa: “You have to talk to the children about it, remind them of the safety rules without creating psychosis” Nov 24, 2022
- Black Friday: Manufacturers warn of the dangers of counterfeiting Nov 21, 2022
- China continues to restrict anime | Atomix Sep 28, 2021
The list of problems between the European Union and the pharmaceutical AstraZeneca in the last year is so long that we have almost lost count, but ordinary citizens do not lose sleep over these disagreements. At least, when people turn to Dr. Miguel Marcos Martín, they don’t ask him that, but rather what is the covid vaccine they should get.
Until a few days ago, in Spain one could not choose a vaccine, but since this week, the one and a half million people under the age of 60 who received a first dose of AstraZeneca now have the option of repeating a second dose with this preparation – signing a consent -, or to complete the guideline with one from Pfizer. And, of course, people have doubts.
Miguel Marcos Martín, internist at the University Hospital of Salamanca and professor at the Department of Medicine at the University of Salamanca, understands the concern of this segment of the population, and at the same time tries to call for calm: “The important thing is not what vaccine is chosen, but no one is left without a second dose ”. “If an option were clearly unsafe, it would not be chosen,” he emphasizes.
The important thing is not which vaccine is chosen, but that no one is left without a second dose
Accustomed to hearing the continuous doubts of his environment about this and other issues during the pandemic, Marcos Martín decided to clarify them with Twitter threads to reach more people. And that’s what it did last Thursday with the Pfizer / AstraZeneca dilemma:
The ‘problem’ is that, although the question is very clear (“which is better?”), The answer is not so clear, and Marcos Martín himself points out this in his second tweet: “We cannot answer this question with security at this time ”. Fortunately, if there is no clear answer yet it is because & ld …
This article originally appeared on The HuffPost and has been updated.
